
Adolescent OSA Management Needs Guideline Update, Says Binal Kancherla, MD
At SLEEP 2025, Kancherla highlights diagnostic dilemmas, treatment gaps, and the need for pediatric criteria when managing obstructive sleep apnea in teens.
Binal Kancherla, MD, from Baylor College of Medicine, presented on the diagnostic and treatment dilemmas when managing
HCPLive sat down with Kancherla during the meeting to discuss the
“I believe that the age group from age 15 to 17 can be the trickiest time,” Kancherla told HCPLive when asked about the need for updated guidelines. “I think there's a discrepancy in a lot of sleep centers across the country and how they're treating that age group, and maybe we need to identify factors that are unique to that age group in treating their OSA.”
As of now, there are no discovered biomarkers to identify OSA in adolescents. Kancherla emphasized the importance of a multidisciplinary approach in treating OSA in this age group, beginning with proper screening and assessment of OSA severity. From there, clinicians should develop a personalized treatment plan tailored to the individual's needs.
Kancherla said untreated OSA during adolescence can result in severe mental health and developmental outcomes. Although there is not a lot of longitudinal data, she pointed out that development impacts school and athletic performance. OSA can also increase the risk of high blood pressure.
“I think there's a combination of problems that we see in this age,” Kancherla said. “Again, we don't know what is going to happen and when it's going to happen. It could be 5 years down the road. It could be 10 years down the road. We just know that the risk is higher. So, it's important to identify OSA and treat it as best we can.”
References















































































